| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An mRNA vaccine elicits STING-dependent antitumor immune responses
|
Chen, Zhe
|
|
|
13 |
3 |
p. 1274-1286
|
article
|
| 2 |
A novel IRAK4/PIM1 inhibitor ameliorates rheumatoid arthritis and lymphoid malignancy by blocking the TLR/MYD88-mediated NF-κB pathway
|
Yoon, Sae-Bom
|
|
|
13 |
3 |
p. 1093-1109
|
article
|
| 3 |
Author correction to “The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway” [Acta Pharm Sin B 12 (2022) 1288–1304]
|
Ye, Geni
|
|
|
13 |
3 |
p. 1337-1339
|
article
|
| 4 |
Author correction to “TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner” [Acta Pharm Sin B 11(12) (2021) 3994–4007]
|
Zheng, Huaqing
|
|
|
13 |
3 |
p. 1340-1343
|
article
|
| 5 |
Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms
|
Yang, Yanfang
|
|
|
13 |
3 |
p. 1036-1052
|
article
|
| 6 |
Concurrent silencing of TBCE and drug delivery to overcome platinum-based resistance in liver cancer
|
Li, Senlin
|
|
|
13 |
3 |
p. 967-981
|
article
|
| 7 |
Cover Story
|
|
|
|
13 |
3 |
p. xii
|
article
|
| 8 |
Development of fluorine-substituted NH2-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors: Boosting the safety and metabolic stability
|
Jin, Xin
|
|
|
13 |
3 |
p. 1192-1203
|
article
|
| 9 |
Dihydrofolate reductase-like protein inactivates hemiaminal pharmacophore for self-resistance in safracin biosynthesis
|
Shao, Ning
|
|
|
13 |
3 |
p. 1318-1325
|
article
|
| 10 |
Discovery of novel phosphodiesterase-1 inhibitors for curing vascular dementia: Suppression of neuroinflammation by blocking NF-κB transcription regulation and activating cAMP/CREB axis
|
Zhou, Qian
|
|
|
13 |
3 |
p. 1180-1191
|
article
|
| 11 |
Discovery of the radio-protecting effect of Ecliptae Herba, its constituents and targeting p53-mediated apoptosis in vitro and in vivo
|
Wu, Jiang
|
|
|
13 |
3 |
p. 1216-1230
|
article
|
| 12 |
G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes
|
Wei, Xiaoli
|
|
|
13 |
3 |
p. 1128-1144
|
article
|
| 13 |
HBXIP blocks myosin-IIA assembly by phosphorylating and interacting with NMHC-IIA in breast cancer metastasis
|
Zhang, Lu
|
|
|
13 |
3 |
p. 1053-1070
|
article
|
| 14 |
Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice
|
Fan, Xiaoqing
|
|
|
13 |
3 |
p. 1164-1179
|
article
|
| 15 |
Lipid nanomaterials-based RNA therapy and cancer treatment
|
Zhang, Xingcai
|
|
|
13 |
3 |
p. 903-915
|
article
|
| 16 |
Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor
|
Shen, Shiyang
|
|
|
13 |
3 |
p. 1262-1273
|
article
|
| 17 |
Membrane dual-targeting probes: A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection
|
Wu, Ling-Ling
|
|
|
13 |
3 |
p. 1204-1215
|
article
|
| 18 |
Mitochondrial transplantation as a promising therapy for mitochondrial diseases
|
Zhang, Tian-guang
|
|
|
13 |
3 |
p. 1028-1035
|
article
|
| 19 |
Mucus-penetrating nonviral gene vaccine processed in the epithelium for inducing advanced vaginal mucosal immune responses
|
Bi, Qunjie
|
|
|
13 |
3 |
p. 1287-1302
|
article
|
| 20 |
Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy
|
Dong, Zhihui
|
|
|
13 |
3 |
p. 955-966
|
article
|
| 21 |
Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis
|
Zhao, Mengnan
|
|
|
13 |
3 |
p. 916-941
|
article
|
| 22 |
Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers
|
Zhang, Lei
|
|
|
13 |
3 |
p. 982-997
|
article
|
| 23 |
Real-time SERS monitoring anticancer drug release along with SERS/MR imaging for pH-sensitive chemo-phototherapy
|
Huang, Xueqin
|
|
|
13 |
3 |
p. 1303-1317
|
article
|
| 24 |
Recent advances in bacterial therapeutics based on sense and response
|
Feng, Zhuo
|
|
|
13 |
3 |
p. 1014-1027
|
article
|
| 25 |
Rhodojaponin VI indirectly targets Cav2.2 channels via N-ethylmaleimide-sensitive fusion protein to alleviate neuropathic pain
|
Chen, Keliang
|
|
|
13 |
3 |
p. 1326-1336
|
article
|
| 26 |
Roles of focal adhesion proteins in skeleton and diseases
|
Chen, Sheng
|
|
|
13 |
3 |
p. 998-1013
|
article
|
| 27 |
ROS-removing nano-medicine for navigating inflammatory microenvironment to enhance anti-epileptic therapy
|
Zhou, Zheng
|
|
|
13 |
3 |
p. 1246-1261
|
article
|
| 28 |
Sodium alginate coating simultaneously increases the biosafety and immunotherapeutic activity of the cationic mRNA nanovaccine
|
Duan, Xing
|
|
|
13 |
3 |
p. 942-954
|
article
|
| 29 |
S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung
|
Hao, Mengyao
|
|
|
13 |
3 |
p. 1110-1127
|
article
|
| 30 |
Table of Contents
|
|
|
|
13 |
3 |
p. iii-xii
|
article
|
| 31 |
Targeting metabolic vulnerability in mitochondria conquers MEK inhibitor resistance in KRAS-mutant lung cancer
|
Feng, Juanjuan
|
|
|
13 |
3 |
p. 1145-1163
|
article
|
| 32 |
The deubiquitinating enzyme 13 retards non-alcoholic steatohepatitis via blocking inactive rhomboid protein 2-dependent pathway
|
Xu, Minxuan
|
|
|
13 |
3 |
p. 1071-1092
|
article
|
| 33 |
The role of phosphatidylcholine 34:1 in the occurrence, development and treatment of ulcerative colitis
|
Yu, Tengjie
|
|
|
13 |
3 |
p. 1231-1245
|
article
|
Journal description